Clinical Trial: Laser Atherectomy and Sirolimus-coated Balloon Angioplasty for CLTI

U.S., Oct. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07858539) titled 'Laser Atherectomy and Sirolimus-coated Balloon Angioplasty for CLTI' on Sept. 29.

Brief Summary: Peripheral arterial disease (PAD) is a widespread pathology affecting over 200 million adults globally and is primarily caused by atherosclerosis. It leads to peripheral arterial stenosis, commonly in the lower extremities, resulting in symptoms ranging from intermittent claudication to chronic limb-threatening ischemia (CLTI). Endovascular interventions are currently considered first-line treatment approaches for PAD. Laser atherectomy offers a minimally invasive endovascular option to effectively debulk atherosclerotic steno-occlusive l...